Visgeneer Inc. (4197.TWO)
TWD 9.9
(-12.0%)
TWD 9.9
(-12.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 31.28 Million TWD | -30.89% |
| 2022 | 45.26 Million TWD | -51.51% |
| 2021 | 93.35 Million TWD | -32.32% |
| 2020 | 137.93 Million TWD | 67.43% |
| 2019 | 82.38 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 56.63 Million TWD | 81.03% |
| 2024 Q2 | 56.63 Million TWD | 0.0% |
| 2023 FY | 31.28 Million TWD | -30.89% |
| 2023 Q2 | 42.58 Million TWD | 0.38% |
| 2023 Q1 | 42.42 Million TWD | -6.28% |
| 2023 Q3 | 31.22 Million TWD | -26.67% |
| 2023 Q4 | 31.28 Million TWD | 0.19% |
| 2022 Q3 | 44.66 Million TWD | 0.0% |
| 2022 Q4 | 45.26 Million TWD | 1.35% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 140.605% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 111.842% |
| Level Biotechnology Inc. | -453.9 Million TWD | 106.892% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 125.947% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 115.929% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 93.741% |
| GlycoNex Incorporation | -148.56 Million TWD | 121.057% |
| VBI | -25.31 Million TWD | 223.574% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 22.307% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 77.33% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 111.914% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | -2.309% |
| Mycenax Biotech Inc. | 207 Million TWD | 84.888% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 104.596% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 123.302% |
| Neith Corporation | -150.31 Million TWD | 120.813% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 94.967% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 154.258% |
| Enimmune corporation | -314.15 Million TWD | 109.958% |
| TaiRx, Inc. | -147.86 Million TWD | 121.157% |
| CHO Pharma, Inc. | -203.79 Million TWD | 115.351% |
| EirGenix Inc. | -4.58 Billion TWD | 100.682% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 136.908% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 74.118% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 100.972% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 109.856% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | 257.896% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 1.65% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 38.363% |
| RBC Bioscience Corporation | 422.18 Million TWD | 92.59% |
| BiOptic Inc. | 12.59 Million TWD | -148.443% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 103.313% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 130.826% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 118.94% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 90.065% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 148.637% |
| NaviFUS Corp. | -123.12 Million TWD | 125.407% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 57.753% |
| Sinew Pharma Inc. | -160.34 Million TWD | 119.51% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 112.933% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 109.273% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 107.581% |
| AP Biosciences Inc | -196.52 Million TWD | 115.918% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 95.458% |
| 3D Global Biotech Inc. | -11.43 Million TWD | 373.533% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 103.771% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 97.695% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 107.541% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 114.944% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 121.746% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 109.464% |
| TCI GENE Inc. | -689.25 Million TWD | 104.539% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 126.303% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 102.39% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -52.732% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 130.71% |
| PharmaEngine, Inc. | -860.8 Million TWD | 103.634% |
| Savior Lifetec Corporation | -812.54 Million TWD | 103.85% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 110.429% |
| OBI Pharma, Inc. | -398.22 Million TWD | 107.856% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 108.561% |
| Acepodia, Inc. | -6.02 Billion TWD | 100.52% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 100.92% |